Copyright
©The Author(s) 2015.
World J Diabetes. Jun 10, 2015; 6(5): 759-773
Published online Jun 10, 2015. doi: 10.4239/wjd.v6.i5.759
Published online Jun 10, 2015. doi: 10.4239/wjd.v6.i5.759
Ref. | Country | Sample size | Type of diabetes | Duration of follow-up | Diagnostic criteria for CKD | Prevalence | Incidence | Comments |
Motala et al[37], 2001 | South Africa | 219 | T1DM and T2DM | 16.10 (4.9) T1DM; 18.6 (5.7) T2DM; at least 10 yr | Persistent proteinuria (dipstix proteinuria on three or more consecutive occasions over 18 mo in the at absence of infection or cardiac failure) | Not applicable | 24.6% | |
Elbagir et al[26], 1995 | Sudan | 128 | Insulin-treated | Not applicable | Proteinuria (≥ 30 mg/dL) | 22% | Not applicable | |
Sobngwi et al[44], 1999 | Cameroon | 64 | T1DM and T2DM | Not applicable | Proteinuria | 53.1% | Not applicable | |
Katchunga et al[30], 2010 | DR Congo | 98 | T2DM | Not applicable | MDRD: CKD stage ≥ 2 according to the National Kidneyfoundation | 18.1% | Not applicable | |
Choukem et al[22], 2012 | Cameroon | 420 | T2DM | Not applicable | Proteinuria (30 mg/24 h) | 31% | Not applicable | |
Keeton et al[31], 2004 | South Africa | 59 | T2DM | 12 yr | Urine Albumin-to-Creatinine Ratio (no detail) | After 12 yr of follow-up or death, 94.9% (56/59) had a proteinuria with a mean duration from diabetes onset to proteinuria of 9.7 (5.9) yr | 83% (49/59) had an elevated SCr atthe end of the study and in 66.1% (39/59) the SCr level had doubled during the study | |
Pruijm et al[39], 2008 | Seychelles | 1218 | All types | Not applicable | Microalbuminuria: Urine Albumin-to-Creatinine Ratio 3.4-33.9 mg albumin/mmol creatinine | 36.1% | Not applicable | |
Alebiosu[16], 2003 | Nigeria | 342 | T1DM and T2DM | Not applicable | Persistent proteinuria | 28.4% | Not applicable | |
Bouaziz et al[20], 2012 | Tunisia | 73 | T2DM | Not applicable | Microalbuminuria: < 2.8 g/mol for women and < 2.3 g/mol for men | 11% | Not applicable | |
Ajayi et al[15], 2014 | Nigeria | 65 | T2DM | Not applicable | MDRD: eGFR ≤ 60 mL/min per 1.73 m2 | 43.1% | Not applicable | |
Levitt et al[32], 1997 | South Africa | 243 | T2DM and T1DM | Not applicable | Urine Albumin-to-Creatinine Ratio > 3.4 mm/mmol | 36.7% | Not applicable | |
Persistent proteinuria (for at least 3 consecutive visits) | 5.3% | |||||||
Majaliwa et al[34], 2007 | Tanzania | 99 | T1DM | Not applicable | Proteinuria (no detail) | 29.3% | Not applicable | |
Marshall et al[36], 2013 | Rwanda | 286 | T1DM | Not applicable | Microalbuminuria: Urine Albumin-to-Creatinine Ratio = 30-299 mg/gMacroalbuminuria or overt nephropathy: Urine Albumin-to-Creatinine Ratio ≥ 300 mg/g | Microalbuminuria: 21%; Macroalbuminuria: 5% | Not applicable | |
Alebiosu et al[18], 2003 | Nigeria | 465 | T2DM | Not applicable | Proteinuria and eGFR | 41.1% | Not applicable | The method for the estimation of the GFR is not indicated |
Gill et al[28], 2005 | South Africa | 88 | T1DM | 20 yr | Persistent dipstick proteinuria | Death of renal cause after 20 yr = 18.4% (9/49) | Death due to chronic renal failure after 20 yr of follow-up was 9/49 (after exclusion of lost to follow) | |
Djrolo et al[24], 2001 | Benin | 152 | T1DM and T2DM | Not applicable | Proteinuria (no detail) | 20% | Not applicable | |
Rotchford et al[43], 2002 | South Africa | 253 | T1DM and T2DM | Not applicable | Microalbuminuria > 2.5 mg/mmol in men or 3.5 mg/mmol in women | 46.4% | Not applicable | |
Rissassi et al[42], 2009 | DR congo | 181 | T1DM | Not applicable | Microalbuminuria: Urine Albumin-to-Creatinine Ratio = 30-299 mg/gMacroalbuminuria: Urine Albumin-to-Creatinine Ratio ≥ 300 mg/g | 21.9% (microalbuminuria) and 7.3% (macroalbuminuria) | Not applicable | |
Rahlenbeck et al[40], 1997 | Ethiopia | 170 | T1DM and T2DM | Not applicable | Microalbuminuria: > 30 mg/LMacroalbuminuria: > 300 mg/L | T1DM: 32% (microalbuminuria) and 15% (macroalbuminuria)T2DM: 37% (microalbuminuria) and 20% (macroalbuminuria) | Not applicable | |
Wanjohi et al[45], 2002 | Kenya | 100 | T2DM | Not applicable | Proteinuria ≥ 20 mg | 26% | Not applicable | |
Nambuya et al[38], 1996 | Uganda | 252 | T1DM and T2DM | Not applicable | Proteinuria (no detail) | 17.1% | Not applicable | Newly diagnosed patients |
Rasmussen et al[41], 2013 | Zambia | 101 | T1DM and T2DM | Not applicable | Microalbuminuria: ACR = 3.5-35.0 for women and 2.5-25.0 mg/mmol for menMacroalbuminuria were ACR> 35.0 for women and > 25.0 for men | Microalbuminuria: 23.8%Macroalbuminuria: 8.9% | Not applicable | There were 33 patients with diabetes alone, and 68 patients with diabetes and hypertension |
Bentata et al[19], 2013 | Morocco | 72 | T1DM | 5 yr | Microalbuminuria: albumin excretion rate 30-300 mg/24 hMacroalbuminuria: albumin excretion rate > 300 mg/24 hNephrotic proteinuria: albumin excretion rate ≥ 3000 mg/24 hRenal failure: eGFR < 60 mL/min (MDRD) | At the time of enrollementMicroalbuminuria: 48.6%Macroalbuminuria: 36.1%Nephrotic proteinuria: 15.3% | The incidence of end stage renal disease after 5 yr: 34.7% | Urinary assays done onadmission were repeated on three specimens atthree-monthly intervals |
Gill et al[27], 2008 | Ethiopia | 105 | T1DM and T2DM | Not applicable | Nephropathy: ACR> 25.0 mg/mmol and retinopathy presentMicroalbuminuria: ACR> 2.5 and < 25.0 mg/mmol in men and > 3.5 and< 25.0 mg/mmol in women | Nephropathy: 2%Microalbuminuria: 51% | Urinary ACR levels (toassess microalbuminuria and nephropathy) were done on59 patients, as those with haematuria and/or urinary infection were excluded | |
Bouzid et al[21], 2011 | Tunisia | 689 | T2DM | Not applicable | CKD: eGFR < 60 mL/min per 1.73 m2 (Cockroft-Gault)Microalbuminuria: albumin excretion rate 30-300 mg/24 hMacroalbuminuria: albumin excretion rate > 300 mg/24 h | CKD: 19.8%Microalbuminuria: 13%Macroalbuminuria: 10.1% | Not applicable | Macroalbuminuria was significantly associated with CKD (P < 0.00001) |
Janmohamed et al[29], 2013 | Tanzania | 369 | T1DM and T2DM | Not applicable | CKD: eGFR < 60 mL/min per 1.73 m2 (Cockroft-Gault) or microalbuminuria (> 20 mg/L) or overt protienuria | CKD: 83.7%eGFR < 60 mL/min per 1.73 m2: 24.7%Microalbuminuria: 45.8%Overt proteinuria: 34.1% | Not applicable | |
Danquah et al[23], 2012 | Ghana | 671 | T2DM | Not applicable | Proteinuria ≥ 20 mg/L | 43% | Not applicable | |
Lutale et al[33], 2007 | Tanzania | 244 | T1DM and T2DM | Not applicable | Microalbuminuria: AER 20-200 μg/minMacroalbuminuria: AER > 200 μg/minRenal failure: eGFR < 60 mL/min per 1.73 m2: | Microalbuminuria: 12.1% (T1DM); 9.8% (T2DM)Macroalbuminuria: 1.1% (T1DM); 7.2% (T2DM)Renal failure: 4.6% (T1DM); 22% (T2DM) | Not applicable | |
Worku et al[46], 2010 | Ethiopia | 305 | T1DM (38%) and T2DM (62%) | Not applicable | Proteinuria (no detail) | 15.7% | Not applicable | |
Makulo et al[35], 2010 | DR Congo | 81 | No precision | Not applicable | Microalbuminuria: ACR 30-299 mg/gMacroalbuminuria: ACR ≥ 300 mg/gRenal failure: eGFR < 60 mL/min per 1.73 m2 | Microalbuminuria: 43.5%Macroalbuminuria: 12%Renal failure: 21.4% | Not applicable | |
Eghan et al[25], 2007 | Ghana | 109 | T1DM and T2DM | Not applicable | Microalbuminuria: ACR 30-300 mg/g | 43.1% | Not applicable | |
Alebiosu et al[17], 2004 | Nigeria | 162 | T2DM | Not applicable | Not applicable | Not applicable | Not applicable | The study did not assess the prevalence or incidence of diabetic nephropathy, but its predictors |
- Citation: Noubiap JJN, Naidoo J, Kengne AP. Diabetic nephropathy in Africa: A systematic review. World J Diabetes 2015; 6(5): 759-773
- URL: https://www.wjgnet.com/1948-9358/full/v6/i5/759.htm
- DOI: https://dx.doi.org/10.4239/wjd.v6.i5.759